Katarina Navjord

Katarina Navjord is a seasoned executive with extensive experience in the pharmaceutical industry. Currently serving as VP, Head Rare Hematology & Oncology and Rare Neurology at Immedica Pharma AB, Katarina oversees global product strategy for these specialized business areas. Previously, leadership roles included Head of Oncology/Hematology for Europe & the Middle East at Immedica, where efforts focused on establishing a new business unit, and Business Unit Director for Scandinavia at AbbVie, managing a Specialty & Eye Care Business Unit with full P&L responsibility. Additional experience includes senior positions in customer excellence and sales management at AbbVie and Pfizer, and consultancy at Arthur D. Little. Katarina holds a Master of Science in Industrial Engineering and Management from Chalmers University of Technology and has studied organizational modelling at Stanford University.